HHS aims to use value-based care payment models to lower drug prices

September 9, 2021Garrett SchmittNo CommentsCMMI, drug prices, HHS, Pharmaceuticals

The Department of Health and Human Services wants to test models that would pay drugs based on their clinical value as part of a new plan to tackle high prices. The plan released Thursday lays out several administrative tools the agency plans to take to address high prices. It also calls on Congress to adopt several reforms…

Recent Posts

  • Value-Based Care Emerges as a Strategic Anchor in an Uncertain Regulatory Climate
  • Around the nation: Optum launches new AI tool for value-based care
  • Podcast: Is Value-Based Payment Failing U.S. Healthcare?
  • Medicare Alternative Payment Models That Support Improved Primary Care
  • RECORDED WEBINAR: The Missing Layer in Value-Based Care: Turning Performance into Financial Truth
 
  • Main Lobby
  • Exhibit Hall
  • Events
  • Exhibit With Us
  • Board Room
  • Library
  • Contact Us